# Permeability MRI in Cerebral Cavernous Malformations Type 1 in New Mexico: Effects of Statins

> **NCT01764451** · EARLY_PHASE1 · TERMINATED · sponsor: **University of New Mexico** · enrollment: 12 (actual)

## Conditions studied

- Cavernous Angioma, Familial
- Cerebral Cavernous Malformations
- Cerebral Cavernous Hemangioma

## Interventions

- **DRUG:** Simvastatin

## Key facts

- **NCT ID:** NCT01764451
- **Lead sponsor:** University of New Mexico
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-03
- **Primary completion:** 2016-01
- **Final completion:** 2016-01
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** Research was completed before January 18, 2017, \& does not meet the Applicable Clinical Trial requirement to register \& report results per the guidance provided in "Clinical Trials Registration \& Results Information Submission" dated 09/21/2016.
- **Last updated:** 2024-03-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01764451

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01764451, "Permeability MRI in Cerebral Cavernous Malformations Type 1 in New Mexico: Effects of Statins". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01764451. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*